MedTrace Logo

The Effectiveness of Albendazole Treatment Among Infected Toxocara Children

NCT05208333 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 960

Last updated 2022-04-20

No results posted yet for this study

Summary

This study consists 2 phases. The first phase will conduct a cross-sectional study to determine the infection rate of Toxocariasis larvae, describe the clinical and paraclinical characteristics, identify risk factors related to Toxocariasis larva infection. The second phase will conduct an interventional study to evaluate the effectiveness and factors related to the Albendazole treatment on pupils infected with Toxocariasis larvae in Ho Chi Minh City.

Conditions

  • Toxocara Infection

Interventions

DRUG

Albenza 200Mg Tablet

Distributing albedazol (Zentel) 200mg at school to parents or guardians, dose 15mg/kg divided into 2 times/day, instructions to take the medicine in full dose, at the right time after meals, for 5 days. Limiting reinfection: Advice on preventing reinfection

Sponsors & Collaborators

  • Department of Science and Technology, Ho Chi Minh City, Viet Nam

    collaborator UNKNOWN

  • Pham Ngoc Thach University of Medicine

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-31
Primary Completion
2023-12-31
Completion
2024-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05208333 on ClinicalTrials.gov